CAR-T cell therapies for cancer: what novel technologies are being developed for toxicity data?
Expert Opin Drug Metab Toxicol
.
2022 Apr;18(4):241-244.
doi: 10.1080/17425255.2022.2085551.
Epub 2022 Jun 13.
Authors
Wiktoria Parol
1
,
Georgina S F Anderson
1
,
Michael A Chapman
1
Affiliation
1
University of Cambridge, MRC Toxicology Unit, Cambridge, UK.
PMID:
35686653
DOI:
10.1080/17425255.2022.2085551
No abstract available
Keywords:
CAR T-cell therapy; CRS; ICANS; novel technologies; toxicity.
Publication types
Editorial
MeSH terms
Humans
Immunotherapy, Adoptive / adverse effects
Neoplasms* / therapy
Neurotoxicity Syndromes*
T-Lymphocytes
Grants and funding
24724/CRUK_/Cancer Research UK/United Kingdom
MC_UU_00025/10/MRC_/Medical Research Council/United Kingdom